|
|||||
|
|
Cost‐effectiveness of single‐dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK |
|
| Authors: | Anna Walker Scott Doyle John Posnett Manjit Hunjan |
| Affiliation: | 1. Heron Evidence Development Ltd, , Luton, UK;2. GlaxoSmithKline, Health Outcomes UK, , Uxbridge, UK |
| Abstract: | |
| Keywords: | benign prostatic hyperplasia cost‐effectiveness Markov model tamsulosin dutasteride Combodart UK |